Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Gontero

Showing results (1-10 of 601) with videos related to

Pageof 61
Sort By:
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|May 12, 2007
[The not-infrequent story of a superficial bladder carcinoma...Discussion of clinical case no.2]Paolo Gontero
European Urology|September 12, 2008
Editorial comment on: Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancerPaolo Gontero
World Journal of Urology|January 23, 2019
SIU-ICUD consultation on bladder cancer 2018Peter Black, Paolo Gontero
Translational Andrology and Urology|April 13, 2018
How to assess and improve health-related quality of life in bladder cancer patientsFrancesco Soria, Paolo Gontero
International Braz J Urol : Official Journal of the Brazilian Society of Urology|January 18, 2008
Re: Lack of association between matrix metalloproteinase-1 (MMP-1) promoter polymorphism and risk of renal cell carcinomaAndrea Zitella, Paolo Gontero
Urologia|April 6, 2013
[Adverse events after intravesical therapy: are we always ready to recognize and prevent them?]Chiara Fiorito, Paolo Gontero
European Urology|February 8, 2021
Re: Intravesical Nadofaragene Firadenovec Gene Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer: A Single-arm, Open-label, Repeat-dose Clinical TrialFrancesco Soria, Paolo Gontero
European Urology|April 28, 2009
Open to debate. The motion: Radiotherapy for prostate cancer preserves sexual function to a greater extent than nerve sparing radical prostatectomyMichael Pinkawa, Paolo Gontero
BJU International|October 13, 2009
High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: is repeat biopsy still necessary?Marco Oderda, Paolo Gontero
European Urology|March 12, 2025
Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia and Alberto Briganti's Letter to the Editor re: Paolo Gontero, Alison Birtle, Otakar Capoun, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update. Eur Urol 2024;86:531-49Paolo Gontero, Francesco Soria,
Pageof 61

Showing results (1-10 of 601) with videos related to

Sort By:
Pageof 61
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|May 12, 2007
[The not-infrequent story of a superficial bladder carcinoma...Discussion of clinical case no.2]Paolo Gontero
European Urology|September 12, 2008
Editorial comment on: Randomized phase II trial evaluation of erectile function after attempted unilateral cavernous nerve-sparing retropubic radical prostatectomy with versus without unilateral sural nerve grafting for clinically localized prostate cancerPaolo Gontero
World Journal of Urology|January 23, 2019
SIU-ICUD consultation on bladder cancer 2018Peter Black, Paolo Gontero
Translational Andrology and Urology|April 13, 2018
How to assess and improve health-related quality of life in bladder cancer patientsFrancesco Soria, Paolo Gontero
International Braz J Urol : Official Journal of the Brazilian Society of Urology|January 18, 2008
Re: Lack of association between matrix metalloproteinase-1 (MMP-1) promoter polymorphism and risk of renal cell carcinomaAndrea Zitella, Paolo Gontero
Urologia|April 6, 2013
[Adverse events after intravesical therapy: are we always ready to recognize and prevent them?]Chiara Fiorito, Paolo Gontero
European Urology|February 8, 2021
Re: Intravesical Nadofaragene Firadenovec Gene Therapy for BCG-unresponsive Non-muscle-invasive Bladder Cancer: A Single-arm, Open-label, Repeat-dose Clinical TrialFrancesco Soria, Paolo Gontero
European Urology|April 28, 2009
Open to debate. The motion: Radiotherapy for prostate cancer preserves sexual function to a greater extent than nerve sparing radical prostatectomyMichael Pinkawa, Paolo Gontero
BJU International|October 13, 2009
High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: is repeat biopsy still necessary?Marco Oderda, Paolo Gontero
European Urology|March 12, 2025
Reply to Francesco Montorsi, Giuseppe Rosiello, Giorgio Gandaglia, Andrea Salonia and Alberto Briganti's Letter to the Editor re: Paolo Gontero, Alison Birtle, Otakar Capoun, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-A Summary of the 2024 Guidelines Update. Eur Urol 2024;86:531-49Paolo Gontero, Francesco Soria,
Pageof 61